Literature DB >> 7534227

Gelatinase A activity directly modulates melanoma cell adhesion and spreading.

J M Ray1, W G Stetler-Stevenson.   

Abstract

Interaction of cells with the extracellular matrix (ECM) plays an important role in the regulation of cell behavior. Formation of adhesive contacts leads to transduction of signals into the cell and results in altered gene expression and modulation of the cellular phenotype. Specific adhesive interactions of the fibronectin and vitronectin receptors with their ligands in the matrix modulates expression of ECM-degrading metalloproteases. These proteases are involved in the acquisition of the invasive phenotype by a number of cell types. The activity of matrix metalloproteases (MMPs) is reduced by endogenous inhibitors referred to as tissue inhibitors of metalloproteases (TIMPs). Alterations in the balance between the activity of MMPs and TIMPs alters cellular invasion through effects on matrix degradation. In this study we demonstrate that inhibition of endogenous gelatinase A activity in A2058 human melanoma cells results in enhanced cellular adhesion. To further explore this phenomenon, we have used retroviral infection vectors to control the amount of the MMP inhibitor TIMP-2 in human melanoma A2058 cells. Altering the production of TIMP-2 modulates not only proteolysis of the extracellular matrix, but also the adhesive and spreading properties of the cells and results in altered cell morphology. These effects of TIMP-2 appear to be mediated by inhibition of gelatinase A activity. We conclude that gelatinase A, in addition to contributing to proteolysis of ECM components, also functions to proteolyse cell surface components that mediate attachment of A2058 cells to the ECM. Thus, gelatinase A may function to modulate cell attachment and facilitate cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534227      PMCID: PMC398163          DOI: 10.1002/j.1460-2075.1995.tb07072.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  52 in total

1.  Improved retroviral vectors for gene transfer and expression.

Authors:  A D Miller; G J Rosman
Journal:  Biotechniques       Date:  1989-10       Impact factor: 1.993

2.  Identification of an inhibitor of neovascularization from cartilage.

Authors:  M A Moses; J Sudhalter; R Langer
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

3.  Differences in the biosynthesis and localization of the fibronectin receptor in normal and transformed cultured human cells.

Authors:  S K Akiyama; H Larjava; K M Yamada
Journal:  Cancer Res       Date:  1990-03-01       Impact factor: 12.701

4.  Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

Authors:  O A Alvarez; D F Carmichael; Y A DeClerck
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

5.  The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation.

Authors:  W G Stetler-Stevenson; H C Krutzsch; M P Wacher; I M Margulies; L A Liotta
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

6.  Metalloproteinases and cancer invasion and metastasis.

Authors:  G Murphy; J J Reynolds; R M Hembry
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

7.  Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.

Authors:  R Tsuboi; D B Rifkin
Journal:  Int J Cancer       Date:  1990-07-15       Impact factor: 7.396

8.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression.

Authors:  Z Werb; P M Tremble; O Behrendtsen; E Crowley; C H Damsky
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

9.  Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression.

Authors:  C J Sympson; R S Talhouk; C M Alexander; J R Chin; S M Clift; M J Bissell; Z Werb
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

10.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion.

Authors:  J Behrens; M M Mareel; F M Van Roy; W Birchmeier
Journal:  J Cell Biol       Date:  1989-06       Impact factor: 10.539

View more
  39 in total

1.  Matricellular proteins as modulators of cell-matrix interactions: adhesive defect in thrombospondin 2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase-2.

Authors:  Z Yang; T R Kyriakides; P Bornstein
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

2.  Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

Authors:  M Luca; S Huang; J E Gershenwald; R K Singh; R Reich; M Bar-Eli
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Tissue inhibitor of metalloproteinase 2 inhibits activation of the β-catenin signaling in melanoma cells.

Authors:  Yuxuan Xia; Shaoping Wu
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.

Authors:  Dimitra Bourboulia; William G Stetler-Stevenson
Journal:  Semin Cancer Biol       Date:  2010-05-12       Impact factor: 15.707

5.  Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.

Authors:  A H Baker; A B Zaltsman; S J George; A C Newby
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

Review 6.  Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.

Authors:  W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

7.  Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin.

Authors:  J J van den Oord; L Paemen; G Opdenakker; C de Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

8.  Regulation of tumor growth and metastasis of human melanoma by the CREB transcription factor family.

Authors:  D Jean; M Bar-Eli
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 9.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

10.  Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-kappaB activity in melanoma cells.

Authors:  Jun Sun; William G Stetler-Stevenson
Journal:  J Mol Signal       Date:  2009-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.